Novel oxaborole analogs for treatment of cutaneous leishmaniasis
Ended Cooperative Agreement Awarded Last action
- Award ID
- W81XWH1420171
- Recipient
-
Anacor Pharmaceuticals, Inc. UEI HGNKDH1DLM86
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $473,020
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Palo Alto, CA 94303, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | -$46,823 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $519,843 |
Quick answers
Who received award W81XWH1420171?
W81XWH1420171 was awarded to Anacor Pharmaceuticals, Inc. by Medical Command (Department of the Army) on September 30, 2014.
How much is award W81XWH1420171 worth?
$473,020 has been obligated on W81XWH1420171.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award